These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15980914)

  • 1. Response to Maubach and Hoek's paper on GP attitudes to DTCA.
    Toop L; Richards D; Dowell T
    N Z Med J; 2005 Jun; 118(1217):U1543. PubMed ID: 15980914
    [No Abstract]   [Full Text] [Related]  

  • 2. New Zealand general practitioners' views on direct-to-consumer advertising of prescription medicines: a qualitative analysis.
    Maubach N; Hoek J
    N Z Med J; 2005 May; 118(1215):U1461. PubMed ID: 15915184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand. 'Possums in the headlights?'.
    Toop L; Richards D; Dowell T
    Br J Gen Pract; 2003 Apr; 53(489):342-5. PubMed ID: 12879848
    [No Abstract]   [Full Text] [Related]  

  • 4. US Congress to consider limits on DTCA.
    Guthrie P
    CMAJ; 2007 May; 176(10):1404. PubMed ID: 17485685
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinicians' responses to direct-to-consumer advertising of prescription medications.
    Zachry WM; Dalen JE; Jackson TR
    Arch Intern Med; 2003 Aug 11-25; 163(15):1808-12. PubMed ID: 12912716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can DTCA bring you patients?
    Newman BY
    J Am Optom Assoc; 1999 Sep; 70(9):561. PubMed ID: 10547970
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug advertisements: what a physician should know.
    Ghosh RK; Ghosh SM
    N Z Med J; 2010 May; 123(1314):154-6. PubMed ID: 20581923
    [No Abstract]   [Full Text] [Related]  

  • 8. Do ads really drive pharmaceutical sales? The true effects of DTC advertising remain a mystery.
    Findlay S
    Mark Health Serv; 2002; 22(1):20-5. PubMed ID: 11881540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows.
    Toop L; Richards D
    N Z Med J; 2004 Jun; 117(1195):U905. PubMed ID: 15282619
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug advertising and perception of mental illness.
    Seidenberg R
    Ment Hyg; 1971 Jan; 55(1):21-31. PubMed ID: 5549642
    [No Abstract]   [Full Text] [Related]  

  • 11. Last time around for DTCA.
    Toop L
    N Z Med J; 2003 Nov; 116(1186):U693; author reply U693. PubMed ID: 14657972
    [No Abstract]   [Full Text] [Related]  

  • 12. Attitudes and beliefs regarding direct-to-consumer advertising of pharmaceutical drugs: an exploratory comparison of physicians and pharmaceutical sales representatives.
    Schulz SA; Broekemier GM; Burkink TJ
    Health Mark Q; 2014; 31(3):279-91. PubMed ID: 25120047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of DTC advertisement content on belief tenacity: a study of appeals and argument types.
    Jalnawala N; Wilkin NE
    Res Social Adm Pharm; 2007 Mar; 3(1):28-46. PubMed ID: 17350556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consumers' preferences for the communication of risk information in drug advertising.
    Davis JJ
    Health Aff (Millwood); 2007; 26(3):863-70. PubMed ID: 17485767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DTC drug ads in the spotlight.
    Guglielmo WJ
    Med Econ; 2006 Sep; 83(18):20. PubMed ID: 17037630
    [No Abstract]   [Full Text] [Related]  

  • 16. Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements.
    Hall DV; Jones SC
    Aust N Z J Public Health; 2008 Oct; 32(5):471-8. PubMed ID: 18959553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing pressure.
    Krasner DM
    Del Med J; 1990 May; 62(5):1029. PubMed ID: 2344894
    [No Abstract]   [Full Text] [Related]  

  • 18. High drug costs seem to keep getting higher.
    Ackerman W
    J Ark Med Soc; 2005 Apr; 101(10):293. PubMed ID: 15839313
    [No Abstract]   [Full Text] [Related]  

  • 19. Healthy conversations. The supplement industry redefines itself.
    Tanaka P; Blatman J
    Mark Health Serv; 2010; 30(4):24-7. PubMed ID: 21189783
    [No Abstract]   [Full Text] [Related]  

  • 20. Competitive dynamics in pharmaceuticals.
    Murphy MN; Smith MC; Barnes JH; Szeinbach SL
    J Health Care Mark; 1995; 15(2):24-33. PubMed ID: 10144664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.